{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Iambic Therapeutics files for Nasdaq IPO","author_name":"techandbusiness.org · Startups, AI","thumbnail_url":"https://techandbusiness.org/api/og/newswire/rRUGZzw4VvMZZDSux9DXku","thumbnail_width":1200,"thumbnail_height":630,"width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Startups, AI</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/rRUGZzw4VvMZZDSux9DXku\" style=\"color:#fff;text-decoration:none;\">Iambic Therapeutics files for Nasdaq IPO</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">AI-assisted drug developer Iambic Therapeutics filed for an initial public offering and applied to list on the Nasdaq Global Select Market under the symbol IAM. The preliminary prospectus does not spe...</p>\n    </blockquote>"}